BG
Bellevue Group Portfolio holdings
AUM
$4.54B
1-Year Return
22.5%
This Quarter Return
-16.23%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$1.45B
AUM Growth
-$125M
(-8%)
Cap. Flow
+$148M
Cap. Flow
% of AUM
10.17%
Top 10 Holdings %
Top 10 Hldgs %
37.98%
Holding
149
New
10
Increased
70
Reduced
43
Closed
11
Top Buys
| 1 |
Align Technology
ALGN
|
$34.4M |
| 2 |
Illumina
ILMN
|
$31.2M |
| 3 |
Intuitive Surgical
ISRG
|
$24.4M |
| 4 |
Teladoc Health
TDOC
|
$24.2M |
| 5 |
Abbott
ABT
|
$15.2M |
Top Sells
| 1 |
KTWO
K2M Group Holdings, Inc
KTWO
|
$15.1M |
| 2 |
Centene
CNC
|
$14.7M |
| 3 |
Edwards Lifesciences
EW
|
$14.6M |
| 4 |
Pacific Biosciences
PACB
|
$13.9M |
| 5 |
SHPG
Shire pic
SHPG
|
$11.6M |
Sector Composition
| 1 | Healthcare | 92.41% |
| 2 | Industrials | 1.04% |
| 3 | Technology | 0.54% |
| 4 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Baxter International
BAX
$12.1B
| $16.8M | 1.1% |
254,543
-8,805
| -3% | -$580K |
|
27
Alnylam Pharmaceuticals
ALNY
$59.9B
| $16.4M | 1.08% |
224,385
+4,494
| +2% | +$328K |
|
|
FIT
28
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $16M | 1.05% |
3,218,884
+704,984
| +28% | +$3.5M |
|
|
WBA
29
DELISTED
Walgreens Boots Alliance
WBA
| $15.2M | 1% |
222,802
-3,216
| -1% | -$220K |
|
|
ALXN
30
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $15.2M | 1% |
155,680
-27,400
| -15% | -$2.67M |
|
31
Qiagen
QGEN
$10.1B
| $15M | 0.99% |
410,511
+283,963
| +224% | +$10.4M |
|
|
AKCA
32
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
| $13.8M | 0.91% |
458,296
+39,800
| +10% | +$1.2M |
|
33
MacroGenics
MGNX
$119M
| $13.6M | 0.89% |
1,066,993
+342,691
| +47% | +$4.35M |
|
34
CareDx
CDNA
$679M
| $13.5M | 0.89% |
536,488
+199,439
| +59% | +$5.01M |
|
|
PRAH
35
DELISTED
PRA Health Sciences, Inc.
PRAH
| $13.1M | 0.86% |
142,300
-24,100
| -14% | -$2.22M |
|
|
ABMD
36
DELISTED
Abiomed Inc
ABMD
| $12.6M | 0.83% |
38,822
+5,687
| +17% | +$1.85M |
|
|
ONC
37
BeOne Medicines Ltd. American Depositary Shares
ONC
$35B
| $11.7M | 0.77% |
83,600
+71,980
| +619% | +$10.1M |
|
38
LivaNova
LIVN
$3.13B
| $11.7M | 0.77% |
127,510
+11,067
| +10% | +$1.01M |
|
|
ALDR
39
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $11.5M | 0.76% |
1,123,813
+218,559
| +24% | +$2.24M |
|
40
Supernus Pharmaceuticals
SUPN
$2.53B
| $11.5M | 0.75% |
345,100
-41,400
| -11% | -$1.38M |
|
41
Insmed
INSM
$30B
| $10.6M | 0.7% |
809,146
+242,845
| +43% | +$3.19M |
|
|
42
Centene
CNC
$14B
| $10.4M | 0.68% |
180,202
-255,840
| -59% | -$14.7M |
|
43
HUTCHMED
HCM
$2.54B
| $10.2M | 0.67% |
440,169
+40,140
| +10% | +$927K |
|
|
GNMK
44
DELISTED
GenMark Diagnostics, Inc
GNMK
| $9.72M | 0.64% |
1,999,540
+660,038
| +49% | +$3.21M |
|
45
Zimmer Biomet
ZBH
$20.8B
| $9.55M | 0.63% |
94,867
| – | – |
|
46
DexCom
DXCM
$31.3B
| $9.32M | 0.61% |
311,232
+24,644
| +9% | +$738K |
|
47
Amgen
AMGN
$152B
| $8.75M | 0.58% |
44,950
+8,000
| +22% | +$1.56M |
|
48
Nektar Therapeutics
NKTR
$641M
| $8.59M | 0.56% |
17,414
+13,713
| +371% | +$6.76M |
|
49
Thermo Fisher Scientific
TMO
$181B
| $8.21M | 0.54% |
36,692
+2,221
| +6% | +$497K |
|
50
Gilead Sciences
GILD
$141B
| $7.69M | 0.51% |
123,000
-14,500
| -11% | -$907K |
|